We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMDC.L Regulatory News (MDC)

  • There is currently no data for MDC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)- Mediclinic International plc

26 May 2023 10:45

RNS Number : 8285A
Morgan Stanley & Co. Int'l plc
26 May 2023
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley & Co. International plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mediclinic International plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Mediclinic International plc

(d) Date dealing undertaken:

25 May 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p ordinary

PURCHASES

26,388

5.0100 GBP

4.9980 GBP

10p ordinary

SALES

242,499

5.0100 GBP

5.0000 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

10p ordinary

CFD

increasing a long position

15,568

118.2095 ZAR

10p ordinary

CFD

increasing a long position

3,410

118.2624 ZAR

10p ordinary

CFD

increasing a long position

775

118.4671 ZAR

10p ordinary

CFD

increasing a long position

3,050

5.0011 GBP

10p ordinary

CFD

increasing a long position

60

5.0035 GBP

10p ordinary

CFD

increasing a short position

514

5.0048 GBP

10p ordinary

CFD

increasing a short position

2,465

5.0050 GBP

10p ordinary

CFD

increasing a short position

18,981

5.0095 GBP

10p ordinary

CFD

increasing a short position

3,720

5.0100 GBP

10p ordinary

CFD

reducing a long position

975

118.1516 ZAR

10p ordinary

CFD

reducing a long position

10,439

118.2006 ZAR

10p ordinary

CFD

reducing a long position

3,700

118.2303 ZAR

10p ordinary

CFD

reducing a long position

4,185

118.3003 ZAR

10p ordinary

CFD

reducing a long position

454

118.3700 ZAR

10p ordinary

CFD

reducing a long position

3,050

5.0100 GBP

10p ordinary

CFD

reducing a short position

63,050

5.0042 GBP

10p ordinary

CFD

reducing a short position

46,513

5.0050 GBP

10p ordinary

CFD

reducing a short position

15,302

5.0050 GBP

10p ordinary

CFD

reducing a short position

27,074

5.0050 GBP

10p ordinary

CFD

reducing a short position

15,178

5.0050 GBP

10p ordinary

CFD

reducing a short position

50,000

5.0053 GBP

10p ordinary

CFD

reducing a short position

25,000

5.0053 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

Date of disclosure:

26 May 2023

Contact name:

Craig Horsley

Telephone number:

+44 141 245-7736

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERDZGZKLVKGFZG
Date   Source Headline
26th May 20234:36 pmRNSForm 8 (DD) - Mediclinic International plc
26th May 20232:45 pmRNSForm 8.3 - MEDICLINIC INTERNATIONAL PLC
26th May 20231:00 pmRNSForm 8.3 - Mediclinic International plc
26th May 202311:33 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic International p
26th May 202311:28 amRNSForm 8.5 (EPT/RI) - Mediclinic International plc
26th May 202311:18 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
26th May 202310:45 amRNSForm 8.5 (EPT/RI)- Mediclinic International plc
26th May 20239:29 amRNSForm 8.5 (EPT/NON-RI)
26th May 20238:00 amRNSScheme of Arrangement becomes effective
26th May 20237:00 amRNSForm 8.3 - Mediclinic International plc
25th May 20233:20 pmRNSForm 8.3 - Mediclinic International plc
25th May 20232:57 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20232:39 pmRNSForm 8.5 (EPT/RI) - Mediclinic International plc
25th May 20232:12 pmRNSForm 8.3 - Mediclinic International plc
25th May 20232:00 pmRNSDirector/PDMR Shareholding
25th May 20232:00 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20232:00 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20232:00 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20231:37 pmRNSForm 8.5 (EPT/RI)- Replacement of Mediclinic
25th May 20231:00 pmRNSCourt Sanction of Scheme of Arrangement
25th May 202311:26 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic International p
25th May 202311:25 amRNSForm 8.5 (EPT/RI) - Mediclinic
25th May 202310:48 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
25th May 202310:34 amRNSForm 8.5 (EPT/RI)- Mediclinic International plc
25th May 202310:34 amRNSForm 8.5 (EPT/RI)
24th May 20233:20 pmRNSForm 8.3 - Mediclinic International plc
24th May 20232:17 pmRNSForm 8.3 - Mediclinic International PLC
24th May 202312:10 pmEQSForm 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
24th May 202312:00 pmRNSForm 8.3 - MEDICLINIC INTERNATIONAL PLC
24th May 202311:10 amRNSForm 8.5 (EPT/NON-RI)
24th May 202311:00 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic International
24th May 202311:00 amRNSForm 8.5 (EPT/RI) - Mediclinic Amendment
24th May 202311:00 amRNSForm 8.5 (EPT/RI) - Mediclinic International plc
24th May 202310:32 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
24th May 202310:18 amRNSForm 8.5 (EPT/RI)- Mediclinic International plc
24th May 20239:30 amRNSConsideration Currency Exchange Rate
23rd May 20234:47 pmRNSForm 8.5 (EPT/RI)-Replacement of Mediclinic
23rd May 20233:20 pmRNSForm 8.3 - Mediclinic International plc
23rd May 20233:19 pmRNSForm 8.3 - Mediclinic International plc
23rd May 20233:00 pmRNSForm 8.3 - Mediclinic International Plc
23rd May 202312:50 pmRNSForm 8 (DD) - Mediclinic International plc
23rd May 202312:19 pmRNSForm 8.3 - MEDICLINIC INTERNATIONAL PLC
23rd May 202311:39 amRNSForm 8.3 - Mediclinic International plc
23rd May 202311:21 amRNSForm 8.5 (EPT/RI) - Mediclinic
23rd May 202310:49 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic
23rd May 202310:15 amRNSForm 8.5 (EPT/RI) - Mediclinic International plc
23rd May 202310:13 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
22nd May 20236:01 pmRNSMediclinic International
22nd May 20233:42 pmRNSForm 8.3 - Mediclinic International Plc
22nd May 20233:34 pmRNSForm 8.3 - Mediclinic International Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.